Patterns Of Use Of Biologic Dmards And Small Molecules In Patients With Inflammatory Arthritis: Combined Data From Four Countries Of Latin America
22/05/2024
Carolina Isnardi* 1, Paloma de Abreu2, Vijaya Rivera Terán3, Maria Celina De la Vega1, María Agustina Alfaro1, Julieta Gamba1, Edson Javier Velozo1, Guillermo Ariel Berbotto1, Mercedes de la Sota1, David Vega Morales3, Iris Colunga Pedraza3, Sandra Sicsik Ayala3, Angel Castillo Ortiz3, Fedra Irazoque Palazuelos3, Sonia Cabrera2, Gabriela Ávila2, Vannia Valinotti2, Mariela Zarza2, Angelica Amarilla2, Evelin Leiva2, Cristina Brunengo4, Darwin Cordovilla4, Macarena Soto4, Belem Acevedo4, Pamela Velázquez4, Mariela Harguindeguy4, Deshire Alpizar3 1On behalf of Biobadasar Registry, Argentine Society of Rheumatology, CABA, Argentina, 2On behalf of Biobadaguay Registry, Paraguayan Society of Rheumatology, Asunción, Paraguay, 3On behalf of the Biobadamex Registry, Mexican College of Rheumatology, Mexico DF, Mexico, 4On behalf of Biobadaguay Registry, Uruguayan Society of Rheumatology, Montevideo, Uruguay
Descargar documento